Trial Profile
SP1 - Early Short-term Antibiotic Therapy in Penetrating Abdominal Trauma.
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 11 May 2022
Price :
$35
*
At a glance
- Drugs Ertapenem (Primary)
- Indications Bacterial infections; Intra-abdominal infections; Postoperative infections; Wound infections
- Focus Therapeutic Use
- 04 Feb 2012 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 04 Feb 2012 Actual patient number (56) added as reported by ClinicalTrials.gov.
- 04 Feb 2012 Actual end date October 2011 added as reported by ClinicalTrials.gov.